ArticleBMC plant biology2025
Development of semi-dwarf Echinacea purpurea by inducing silencing of the endogenous brassinosteroid-biosynthetic gene DWF4.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Phytochemical Diversity to Clinical Translation: Preparation-Dependent Bioactivity ofInternational journal of molecular sciences · 2026Review
- Genetically Modified Plants in Agriculture.Biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Brassinosteroids (BRs) are plant steroidal hormones that are crucial for plant growth and development, with dwarfism being a hallmark of BR deficiency. DWARF4 (DWF4) is a key enzyme that catalyzes the rate-limiting C22 oxidation step in the BR biosynthetic pathway. Understanding its role in ornamental plants is crucial for developing dwarf varieties that can significantly enhance their aesthetics and broaden their applications. This study aimed to provide the functional analysis of the DWF4 gene isolated from Echinacea purpurea. We found that the EpDWF4 gene comprised a 1458 bp open reading frame that encodes 486 amino acids and is highly expressed in leaves. EpDWF4 showed high homology to AtCYP90B1, a steroid 22-alpha-hydroxylase involved in the BR biosynthetic pathway in Arabidopsis thaliana. Transgenic E. purpurea plants with suppressed EpDWF4 expression were generated using an RNA interference vector that produced hairpin-looped double-stranded RNAs, leading to sequence-specific RNA silencing of EpDWF4. This resulted in a dwarf phenotype. The physiological function of EpDWF4 was evaluated through complementation in Arabidopsis plants. EpDWF4 completely rescued the extremely dwarf phenotype of the A. thaliana dwf4-102 mutant. In addition, transgenic homozygous A. thaliana plants containing a copy of 35S: EpDWF4 in the intergenic region significantly increased in height. Moreover, steroid 22-alpha-hydroxylase activity, which converts campestanol to 6-deoxocathasterone, increased by 43% in these transgenic plants compared to wild-type A. thaliana. Our results indicate that the knockdown of BR biosynthesis-related genes by RNA interference (RNAi) supports valuable dwarf plant production for commercial horticultural or agricultural applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.